Again, sp may not come back?
In the end if AborGen lives up to its promise, whether one invests at 21c or 26c should not really matter.
https://www.nasdaq.com/markets/ipos/...c-838281-65315
The IPO indicative value of NZ$660m a few years ago provides an indication of upside potential - $1.35 per share.
IPO was pulled if you recall due to litigation brought by disaffected employees who believed they should also have big slice of the upside potential. Law suit was ultimately settled out of court with minimal impact on Aborgen and Rubicon.